{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:16:47Z","timestamp":1787894207007,"version":"build-2784847793"},"reference-count":45,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"crossref","award":["J3-2535"],"award-info":[{"award-number":["J3-2535"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"crossref","award":["P3-0449"],"award-info":[{"award-number":["P3-0449"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"award":["J3-2535"],"award-info":[{"award-number":["J3-2535"]}],"id":[{"id":"https:\/\/ror.org\/059bp8k51","id-type":"ROR","asserted-by":"publisher"}]},{"award":["P3-0449"],"award-info":[{"award-number":["P3-0449"]}],"id":[{"id":"https:\/\/ror.org\/059bp8k51","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Endometrial cancer (EC) is the most common gynecological malignancy with rising incidence, yet reliable non-invasive prognostic biomarkers for preoperative risk stratification and treatment guidance are needed. This pilot study investigated whether plasma levels of aldo-keto reductase family 1 member B1 (AKR1B1) and aldo-keto reductase family 1 member B10 (AKR1B10) could serve as non-invasive prognostic biomarkers in EC. Plasma samples were collected preoperatively from 78 postmenopausal women with histologically confirmed EC alongside clinicopathological data including histological grade, depth of myometrial invasion, lymphovascular invasion, and metastatic status. AKR1B1 and AKR1B10 protein levels were quantified using enzyme-linked immunosorbent assays (ELISAs) in 72 and 64 plasma samples, respectively, and data were analyzed using R v4.3.0. Plasma AKR1B10 levels were significantly higher in Grade 3 compared to Grade 1\u20132 EC patients; and should be considered with caution given the limited Grade 3 sample size. A model combining both AKR1B1 and AKR1B10 with clinical variables (BMI, age, smoking, parity, hormone replacement therapy, previous use of contraceptives) showed limited discriminative ability for preoperative lymphovascular invasion prediction and is not suitable for clinical use in its current form. Survival analysis revealed that patients with plasma levels of both AKR1B1 and AKR1B10 below the median showed significantly better overall (p = 0.04, hazard ratio (HR) = 0.33, 95% confidence interval (CI): 0.10\u20131.01) and recurrence-free survival (p = 0.005, HR = 0.09, 95% CI: 0.02\u20130.49) compared to the remainder of the cohort. These preliminary, hypothesis-generating findings suggest the potential of circulating AKR1B proteins as candidate prognostic biomarkers in EC, requiring prospective validation in larger cohorts.<\/jats:p>","DOI":"10.3390\/ijms27177639","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:05:46Z","timestamp":1787735146000},"page":"7639","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AKR1B1 and AKR1B10 as Potential Prognostic Biomarkers of Endometrial Cancer"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-7729","authenticated-orcid":false,"given":"Maja","family":"Novak Pu\u0161i\u0107","sequence":"first","affiliation":[{"name":"Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-2130","authenticated-orcid":false,"given":"\u0160pela","family":"Smrkolj","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Division of Gynaecology and Obstetrics, University Medical Centre, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-4081","authenticated-orcid":false,"given":"Tea Lani\u0161nik","family":"Ri\u017ener","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: More than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_3","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","first-page":"100056","article-title":"Current challenges and emerging tools in endometrial cancer diagnosis","volume":"35","author":"Canton","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-023-01757-3","article-title":"Minimally invasive approaches for the early detection of endometrial cancer","volume":"22","author":"Shen","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Njoku, K., Barr, C.E., and Crosbie, E.J. (2022). Current and Emerging Prognostic Biomarkers in Endometrial Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.890908"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3802\/jgo.2023.34.e85","article-title":"FIGO staging of endometrial cancer: 2023","volume":"34","author":"Berek","year":"2023","journal-title":"J. Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/his.15272","article-title":"Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinoma","volume":"86","author":"Peters","year":"2025","journal-title":"Histopathology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/IGC.0b013e3181abb0c0","article-title":"Clinical Value of Immunohistochemically Detected Lymphatic and Vascular Invasions in Clinically Staged Endometrioid Endometrial Cancer","volume":"19","author":"Nibbs","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Oliver-Perez, M.R., Padilla-Iserte, P., Arencibia-Sanchez, O., Martin-Arriscado, C., Muruzabal, J.C., Diaz-Feij\u00f3o, B., Cabrera, S., Coronado, P., Mart\u00edn-Salamanca, M.B., and Pantoja-Garrido, M. (2023). Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group. Cancers, 15.","DOI":"10.3390\/cancers15092612"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40001-023-01084-9","article-title":"The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer","volume":"28","author":"Yarandi","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/IGC.0000000000000490","article-title":"Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer","volume":"25","author":"Burzawa","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.3802\/jgo.2021.32.e11","article-title":"Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer","volume":"32","author":"Tortorella","year":"2021","journal-title":"J. Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3802\/jgo.2015.26.3.208","article-title":"Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion","volume":"26","author":"Mahdi","year":"2015","journal-title":"J. Gynecol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Njoku, K., Chiasserini, D., Whetton, A.D., and Crosbie, E.J. (2019). Proteomic Biomarkers for the Detection of Endometrial Cancer. Cancers, 11.","DOI":"10.3390\/cancers11101572"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Thenrajan, T., Alwarappan, S., and Wilson, J. (2023). Molecular Diagnosis and Cancer Prognosis-A Concise Review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13040766"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/pharmrev.120.000122","article-title":"Aldo-Keto Reductases and Cancer Drug Resistance","volume":"73","author":"Penning","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.steroids.2013.10.012","article-title":"Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism","volume":"79","author":"Penning","year":"2014","journal-title":"Steroids"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ri\u017ener, T.L. (2012). Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases. Front. Pharmacol., 3.","DOI":"10.3389\/fphar.2012.00034"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1111\/jcmm.15581","article-title":"Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential","volume":"24","author":"Khayami","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Endo, S., Matsunaga, T., and Nishinaka, T. (2021). The Role of AKR1B10 in Physiology and Pathophysiology. Metabolites, 11.","DOI":"10.3390\/metabo11060332"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e13390","DOI":"10.1111\/sji.13390","article-title":"Role of AKR1B10 in inflammatory diseases","volume":"100","author":"Guo","year":"2024","journal-title":"Scand. J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1210\/jc.2010-1589","article-title":"The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium","volume":"96","author":"Bresson","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1158\/0008-5472.CAN-05-0101","article-title":"A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas","volume":"65","author":"Sales","year":"2005","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/JME-10-0064","article-title":"Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms","volume":"46","author":"Cheng","year":"2011","journal-title":"J. Mol. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Fagerberg","year":"2015","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Laffin, B., and Petrash, J.M. (2012). Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers. Front. Pharmacol., 3.","DOI":"10.3389\/fphar.2012.00104"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s13402-017-0351-7","article-title":"Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer","volume":"40","author":"Taskoparan","year":"2017","journal-title":"Cell Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cbi.2012.11.001","article-title":"Decreased levels of AKR1B1 and AKR1B10 in cancerous endometrium compared to adjacent non-cancerous tissue","volume":"202","author":"Hevir","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hojnik, M., Frkovi\u0107 Grazio, S., Verdenik, I., and Ri\u017ener, T.L. (2021). AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas. Cancers, 13.","DOI":"10.3390\/cancers13143398"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"408047","DOI":"10.1155\/2014\/408047","article-title":"Levels of soluble E-cadherin in breast, gastric, and colorectal cancers","volume":"2014","author":"Repetto","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16709","DOI":"10.1038\/s41598-020-73866-8","article-title":"Multicompartment modeling of protein shedding kinetics during vascularized tumor growth","volume":"10","author":"Machiraju","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_34","unstructured":"O\u2019Connor, O.A. (2023). The Biological Basis for Targeting Protein Turnover in Malignant Cells. Precision Cancer Therapies, Volume 1: Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice, Wiley-Blackwell. [1st ed.]."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"118953","DOI":"10.1016\/j.ejmech.2026.118953","article-title":"Unlocking new frontiers in AKR1B10 inhibition and future opportunities","volume":"315","author":"Yeasrim","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100974","DOI":"10.1016\/j.jhepr.2023.100974","article-title":"AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma","volume":"6","author":"Syamprasad","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.breast.2016.11.003","article-title":"Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers","volume":"31","author":"Reddy","year":"2017","journal-title":"Breast"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/curroncol30010007","article-title":"Overexpression of AKR1B10 Predicts Poor Prognosis in Gastric Cancer Patients Undergoing Surgical Resection","volume":"30","author":"Liu","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/carcin\/bgaa072","article-title":"Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway","volume":"41","author":"Seza","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hlife.2023.12.002","article-title":"Aldo-keto reductase 1B: Much learned, much more to do","volume":"2","author":"Zhao","year":"2024","journal-title":"hLife"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Cao, Z., Delfino, K., Tiwari, V., Wang, X., Hannan, A., Zaidi, F., McClintock, A., Robinson, K., Zhu, Y., and Gao, J. (2022). AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.727505"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/hep.30519","article-title":"A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma","volume":"69","author":"Ye","year":"2019","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00535-019-01551-3","article-title":"Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis","volume":"54","author":"Kanno","year":"2019","journal-title":"J. Gastroenterol."},{"key":"ref_44","unstructured":"R Core Team (2023). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Little, R.J.A., and Rubin, D.B. (2002). Single Imputation Methods. Statistical Analysis with Missing Data, John Wiley & Sons. [2nd ed.].","DOI":"10.1002\/9781119013563"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7639\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:21:34Z","timestamp":1787890894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":45,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177639"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177639","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}